Bayesian decision theory for clinical trials: Utility and sample size determination-Reference-Cited by-同舟云学术

Bayesian decision theory for clinical trials: Utility and sample size determination

Published:2020 Issue:1 Volume:41 Page:55-91
ISSN:0918-4430
Container-title:Japanese Journal of Biometrics
language:en
Short-container-title:Jpn J Biomet

Author:

Sakamaki Kentaro¹,Kanekiyo Michio²,Ohwada Shoichi³,Matsuura Kentaro⁴,Kakizume Tomoyuki⁵,Takahashi Fumihiro⁶,Takazawa Akira⁷,Hagihara Shunsuke⁷,Morita Satoshi⁸

Affiliation:

1. Center for Data Science, Yokohama City University

2. Biostatistics, Neurology Business Group, Eisai Inc.

3. Biostatistics & Data Management Department, R&D Division, Daiichi-Sankyo Co., Ltd

4. Biostatistics, Janssen Pharmaceutical K.K.

5. Integrated Biostatistics Japan Department, Novartis Pharma K.K.

6. Data Science Department, Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation

7. Data Science, ONO Pharmaceutical co., ltd.

8. Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine

Publisher

The Biometric Society of Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjb/41/1/41_55/_pdf

Reference40 articles.

1. Berger, J. O. (1985). Statistical decision theory and Bayesian analysis. Springer.

2. Brockwell, A. E., and Kadane, J. B. (2003). A gridding method for Bayesian sequential decision problems. Journal of Computational and Graphical Statistics, 12, 566-584.

3. Brunier, H. C., and Whitehead, J. (1994). Sample sizes for phase II clinical trials derived from Bayesian decision theory. Statistics in Medicine 13, 2493-2502.

4. Chaudhuri, S. E., Ho, M. P., Irony, T., Sheldon, M., and Lo, A. W. (2018). Patient-centered clinical trials for medical devices. Drug Discovery Today 23, 395-401

5. Cheng, Y., Su, F., and Berry, D. A. (2003). Choosing sample size for a clinical trial using decision analysis. Biometrika 90, 923-936.